Sugi Predict

Sugi Predict / Targets / RCSD1

RCSD1

CapZ-interacting protein · Q6JBY9 · RCSD1 on Sugi Atlas →

0 patent compounds predicted against RCSD1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to RCSD1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With Golimumab PHASE4UNKNOWN
Management of Retinitis Pigmentosa Via Combination of Wharton's Jelly-derived Mesenchymal Stem Cells and Magnovision PHASE3COMPLETED
Repurposing Chlorpromazine in the Treatment of Glioblastoma PHASE2UNKNOWN
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck PHASE1COMPLETED
Evaluation of the Safety and the Tolerability of a Combination of Two HIV Inducers in Patients With Undetectable Viral Load PHASE1COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors PHASE1COMPLETED
Rab 32 Gene Polymorphisms as a Prognostic Factor in Leprosy Patients nanRECRUITING
LGMD R1 Natural History Study nanACTIVE_NOT_RECRUITING
Tecfidera Diffusion Tensor Imaging nanCOMPLETED
Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM) nanCOMPLETED
Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants. nanUNKNOWN
Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated Anomalies nanRECRUITING
Investigation of Methylation of EGFR in the Response of the Cetuximab in Metastatic Colorectal Cancer Patients nanCOMPLETED
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
Study of the Pathophysiological Mechanisms Involved in Bleeding Events nanCOMPLETED
Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease nanRECRUITING
Inflammasomes in Cell Death in FTMH, ERM, and RRD nanCOMPLETED
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
Clinical and Biochemical Features for the Identification of Dominant Calpainopathies nanUNKNOWN
PCD New Gene Discovery nanCOMPLETED
Clinical Characterization on PDE6A-related Retinitis Pigmentosa in Preparation to a Gene Therapy Trial nanCOMPLETED
MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study) nanCOMPLETED
Genetic Study of Patients With Primary Ciliary Dyskinesia nanCOMPLETED
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Autophagy Bladder Cancer nanUNKNOWN
Identification of Genetic Basis of Atrioventricular Conduction Defects: From Congenital Forms to Degenerative Forms nanUNKNOWN
Characterization of Microbiological and Genetic Features in Prostate Cancer and Their Association with Disease Stage nanENROLLING_BY_INVITATION

Related proteins — ESM-2 sequence neighbours (a RCSD1 binder may also engage these)

ProteinNameSimilarity
Q3ZBT0 — 1.000 Q3ZBT0 →
Q3UZA1 — 0.998 Q3UZA1 →
Q6NV74 — 0.982 Q6NV74 →
Q5PR69 — 0.982 Q5PR69 →
Q6ZU35 — 0.981 Q6ZU35 →
Q8CCJ4 — 0.978 Q8CCJ4 →
Q6ZNL6 — 0.977 Q6ZNL6 →
Q32LQ1 — 0.976 Q32LQ1 →
A2AJI0 — 0.974 A2AJI0 →
Q8TD55 — 0.974 Q8TD55 →
Q9NWN3 — 0.974 Q9NWN3 →
F1LR10 — 0.974 F1LR10 →
Q60829 — 0.973 Q60829 →
Q8N7J2 — 0.972 Q8N7J2 →
B0KYV5 — 0.972 B0KYV5 →
Q3KQU3 — 0.971 Q3KQU3 →
Q8K124 — 0.971 Q8K124 →
Q5T6C5 — 0.971 Q5T6C5 →
A2AI08 — 0.971 A2AI08 →
D3ZFB6 — 0.971 D3ZFB6 →
Q5JR59 — 0.971 Q5JR59 →
O00515 — 0.971 O00515 →
Q7Z6L0 — 0.971 Q7Z6L0 →
O75128 — 0.971 O75128 →
Q6J4I0 — 0.971 Q6J4I0 →
PPP1R1B Protein phosphatase 1 regulatory subunit 1B 0.970 landscape →
O75410 — 0.970 O75410 →
A0A8I5ZM56 — 0.969 A0A8I5ZM56 →
Q3USH1 — 0.969 Q3USH1 →
Q9NYF0 — 0.969 Q9NYF0 →